A clinical role of staging laparoscopy with contrast-enhanced intraoperative ultrasonography and indocyanine green fluorescent imaging for pancreatic ductal adenocarcinoma

A clinical role of staging laparoscopy with contrast-enhanced intraoperative ultrasonography and indocyanine green fluorescent imaging for pancreatic ductal adenocarcinoma - SLING trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026937

Enrollment

Registered

2017-04-12

Start date

2017-04-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic ductal adenocarcinoma

Interventions

Staging laparoscopy with indocyanine green fluorescent imaging and contrast-enhanced intraoperative ultrasonography for diagnosing occult distant organ metastasis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pancreatic ductal adenocarcinoma patients with CA19-9>300U/ml and tumor size>30mm

Exclusion criteria

Exclusion criteria: Patients with allagy for iodeine or indocyanine green. Cirrehosis patients with ICGR15>40.

Design outcomes

Primary

Measure	Time frame
Detection rate of distant organ metastasis	—

Secondary

Measure	Time frame
Comparison of survival rate according to the presence or absence of distant organ metastasis;	—

Countries

Japan

Contacts

Public ContactAtsushi Oba

Cancer Institute Hospital, Japanese Foundation for Cancer Research Department of Hepatobiliary Pancreatic Surgery

atsushi.oba@jfcr.or.jp03-3520-0111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026